Spyre Therapeutics News and Activities

Spyre Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Spyre Therapeutics is a company listed under the stock ticker AGLE (US).

Acquisition, funding and merger involving Spyre Therapeutics.

• Spyre Therapeutics has just announced a $316 Million fundraising (posted on January 14 2026).

View the org chart displaying its 27 main executives

Most searched biographies at Spyre Therapeutics

• Cameron Turtle, Chief Executive Officer and Director
• Jeffrey Albers, Director
• Sandra Milligan, Director

Popular executive movements at Spyre Therapeutics

• Peter Harwin, Director, has left the company  (posted on June 1 2026).

Create your alert
to follow the executive moves at Spyre Therapeutics.

Spyre Therapeutics has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Spyre Therapeutics

• Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces Grants of Inducement Awards
• Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
• Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces Grants of Inducement Awards
• Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics to Participate in Upcoming November Investor Conferences
• Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces Grants of Inducement Awards
• Aeglea BioTherapeutics to Participate in Upcoming September Conference
• Aeglea BioTherapeutics Announces Reverse Stock Split
• Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
• Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
• Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma
• View more press releases Close

Social media about Spyre Therapeutics

• Spyre Therapeutics on Wikipedia, Google News & Yahoo Finance
• Spyre Therapeutics on LinkedIn, X (Twitter) & YouTube